BRD2 anticorps (Internal Region)

N° du produit ABIN6657772

Détail du produit anti-BRD2 anticorps

Antigène: BRD2 (Bromodomain Containing 2 (BRD2))

Épitope: Internal Region

Reactivité: Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BRD2 est non-conjugé

Application: Western Blotting (WB), ELISA

Réactivité croisée (Details): Cross reactivity with Brd2 from other species not tested.

Purification: Anti-Brd2 Antibody is monospecific antiserum processed by delipidation and defibrination followed by sterile filtration.

Immunogène:

Immunogen: Anti-Brd2 Antibody was produced in rabbits by repeated immunizations with a synthetic peptide containing an amino acid sequence from the internal part of mouse Brd2.

Immunogen Type: Peptide

Information d'application

Indications d'application:

Application Note: Anti-Brd2 Antibody is suitable for ELISA and Western Blots. Specific conditions for reactivity should be optimized by the end user.  Expect a band approximately 68 kDa in the appropriate cell lysate or extract.

ELISA Dilution: 1:100

Western Blot Dilution: 1:1,000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer:

0.01 % (w/v) Sodium Azide

Stabilizer: None

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: RT,4 °C,-20 °C

Stockage commentaire: Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

Détails sur BRD2

Antigène: BRD2 (Bromodomain Containing 2 (BRD2))

Autre désignation: Brd2 (BRD2 Produits)

Synonymes: anticorps D6S113E, anticorps FSH, anticorps FSRG1, anticorps NAT, anticorps RING3, anticorps RNF3, anticorps AW228947, anticorps D17H6S113E, anticorps Frg-1, anticorps Fsrg-1, anticorps Fsrg1, anticorps Nat, anticorps Ring3, anticorps Rnf3, anticorps mKIAA4005, anticorps brd2-a, anticorps fsh, anticorps fsrg1, anticorps nat, anticorps ring3, anticorps rnf3, anticorps brd2, anticorps fe47f02, anticorps fi85h05, anticorps wu:fe47f02, anticorps wu:fi85h05, anticorps Ring3 protein, anticorps bromodomain containing 2, anticorps bromodomain containing 2 S homeolog, anticorps bromodomain containing 2a, anticorps CHLREDRAFT_190116, anticorps CHLREDRAFT_150233, anticorps CHLREDRAFT_182576, anticorps CHLREDRAFT_188250, anticorps BRD2, anticorps Brd2, anticorps brd2.S, anticorps brd2a

Sujet:

Synonyms: Bromodomain-containing protein 2, Female sterile homeotic-related protein 1, Fsrg-1, Protein RING3

Background: Brd2, a mitogen-activated kinase localized to the nucleus, is a putative transcriptional regulator which interacts with E2F1 and with histone H4 acetylated at 'Lys-13'. It is expressed during development and may be involved in growth control. Brd2 also may play a role in spermatogenesis or folliculogenesis and may be involved in some types of leukemia and in juvenile myoclonic epilepsy. Anti-Brd2 Antibody is ideal for research Gene Expression, Cell Cycle Control and Cancer.

Gene Name: BRD2

ID gène: 14312

NCBI Accession: NP_001191902

UniProt: Q7JJ13

Pathways: Chromatin Binding, SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2